Company: GDSTR
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001213900-25-014248
Chunk: 91

Company: Goldenstone Acquisition Ltd.
Filing Date: 2025-02-14
Form: 10-Q
Item: Item 8
Chunk 91
---
ly based on the weighted average number of shares outstanding between
the redeemable and non-redeemable Common Stock. Any remeasurement of the accretion to redemption value of the Common Stock subject to
possible redemption was considered to be dividends paid to the public stockholders. For the three and nine months ended December 31, 2024
and 2023, the Company has not considered the effect of a) the Public and Private Warrants sold in the Initial Public Offering to purchase
an aggregate of 6,101,250 shares, b) the Public and Private Rights that will automatically convert into an aggregate of 610,125 shares
upon consummation of its initial Business Combination, c) the Unit Purchase Option (“UPO”) to purchase up to 270,250 Units,
which include option to purchase 270,250 shares, option to purchase an aggregate of 270,250 shares from the exercise of warrants, and
27,025 shares automatically converted from the 270,250 rights upon consummation of its initial Business Combination, and d) up to 232,500
Private Units upon optional conversion of the Working Capital and Extension Loans, in the calculation of diluted net income (loss) per
share, since the exercise of the Public and Private Warrants, the effect of the Public and Private Rights, the exercise of the UPO, and
the conversion of the Working Capital and Extension Loans are contingent upon the occurrence of future events and the inclusion of these
financial securities would be anti-dilutive. The Company did not have any other dilutive securities and other contracts that could, potentially,
be exercised or converted into Common Stock and then share in the earnings of the Company. As a result, diluted income (loss) per share
is the same as basic (income) loss per share for the periods presented.

The net income (loss) per share presented in the statement of operations
is based on the following:

    For the Three Months Ended December 31,  2024  
    For the Three Months Ended December 31,  2023  
    For the Nine Months Ended December 31,  2024  
    For the  Nine Months Ended  December 31,  2023 
  
    Net income 
    $18,240  
    $562,676  
    $99,459  
    $904,790 
  
    Accretion of redeemable common stock to redemption value